Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

JPMorgan Chase & Co. Issues Pessimistic Forecast for Ionis Pharmaceuticals (NASDAQ:IONS) Stock Price

Summary by MarketBeat
JPMorgan Chase & Co. dropped their price objective on shares of Ionis Pharmaceuticals from $76.00 to $70.00 and set an "overweight" rating on the stock in a research note on Tuesday.

1 Articles

MarketBeatMarketBeat
Center

JPMorgan Chase & Co. Issues Pessimistic Forecast for Ionis Pharmaceuticals (NASDAQ:IONS) Stock Price

JPMorgan Chase & Co. dropped their price objective on shares of Ionis Pharmaceuticals from $76.00 to $70.00 and set an "overweight" rating on the stock in a research note on Tuesday.

·Sioux Falls, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Tuesday, September 22, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Carlsbad, California icon

Carlsbad, California

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal